A Reminder App for Supporting Adherence to Treatment Goals in Parkinson's Disease
Trial
N/A
Completed
Sept. 25, 2022
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
Trial
Phase 2
Completed
Sept. 25, 2022
Serious Games for Parkinson's Disease
Trial
N/A
Unknown
Sept. 21, 2022
Using Wearable and Mobile Data to Diagnose and Monitor Movement Disorders
Trial
N/A
Unknown
Sept. 20, 2022
Yoga for Anxiety in Adults
Trial
N/A
Completed
Sept. 20, 2022
Effects of Exenatide on Motor Function and the Brain
Trial
Phase 1
Completed
Sept. 15, 2022
Physiological Flow of Liquids Used in Dysphagia Management (Neuro)
Trial
N/A
Completed
Sept. 14, 2022
Acute Effects of Medium Chain Triglyceride (MCT) Nutritional Ketosis on Parkinson's Disease (PD) Symptoms and Biomarkers (MCT-PD)
Trial
Phase 1
Completed
Sept. 12, 2022
Exenatide Treatment in Parkinson's Disease
Trial
Phase 2
Unknown
Sept. 12, 2022
Brain Perfusion & Oxygenation in Parkinson's Disease With NOH
Trial
Phase 4
Completed
Sept. 5, 2022
Gut Health and Probiotics in Parkinson's (SymPD)
Trial
N/A
Unknown
Sept. 1, 2022
Parkinsonian Patients Treated With Apomorphine Pump: Observatory of Skin Lesions
Trial
N/A
Unknown
Aug. 31, 2022
Whey Protein Supplementation in Patients With Parkinson's Disease
Trial
N/A
Completed
Aug. 30, 2022
Effect of Aerobic Training on Oxidative Stress Markers in Patients With Parkinson's Disease
Trial
N/A
Unknown
Aug. 24, 2022
Digital GaitCare - Therapy Monitoring in the Home Environment of Patients With Parkinson
Trial
N/A
Completed
Aug. 23, 2022
Evaluation of a Semiconductor Camera for the DaTSCANā¢ Exam
Trial
N/A
Completed
Aug. 23, 2022
Investigating Cerebellar Inhibition and Its Clinical Significance in Parkinsonian Tremor and Intention Tremor
Trial
N/A
Unknown
Aug. 22, 2022
Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients
Trial
Early Phase 1
Completed
Aug. 18, 2022
Mapping the Target for the MRgFUS Treatment of Tremor
Trial
N/A
Completed
Aug. 14, 2022